Pharmidex is a UK-based CRO, founded in 2002, providing high quality, cost-effective and rapid solutions to clients in in vitro ADME, drug metabolism and pharmacokinetics (DMPK), bioanalysis (non-GLP, GLP/GCP), toxicology (non-GLP, GLP) and histology/clinical chemistry/ haematology.  Pharmidex also offers in silico modelling and efficacy models supporting oncology, CNS, respiratory, stroke, autoimmune and metabolic disease programmes.   

Working with 250+ global clients, including medical charities, academic groups, biotech and pharma, undertaking 15000+ studies. In addition to our fee-for-service offering, Pharmidex is always seeking opportunities to collaborate in grant funded projects. We have successfully participated in 30+ collaborative grant funded projects to date.